James Stanley
Family · South Williamson, KYNPI 1568983195
Payments from drug & device makers
Across 108 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$263
- Novartis$259
- AbbVie$217
- Novo Nordisk$185
- AstraZeneca$153
- Lilly USA, LLC$128
- plus $698 from 18 others
What the payments were for
- Food & beverage$1,902100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 15 | $263 |
| Novartis | 15 | $259 |
| AbbVie | 10 | $217 |
| Novo Nordisk | 11 | $185 |
| AstraZeneca | 9 | $153 |
| Lilly USA, LLC | 8 | $128 |
| Pfizer | 4 | $95 |
| Merck | 5 | $86 |
| Daiichi Sankyo Inc. | 5 | $75 |
| Xeris Pharmaceuticals, Inc. | 4 | $63 |
| Sunovion Pharmaceuticals Inc. | 5 | $59 |
| Redhill Biopharma Inc. | 3 | $55 |
| Boehringer Ingelheim | 3 | $54 |
| Grifols USA, LLC | 1 | $26 |
| Optinose US, Inc. | 1 | $25 |
| Amgen | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Indivior Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,902 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 143 | $135,952 |
| FarxigaDapagliflozin Propanediol | 73 | $62,920 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $62,650 |
| XifaxanRifaximin | 15 | $55,097 |
| EliquisApixaban | 57 | $39,194 |
| TrulicityDulaglutide | 35 | $38,900 |
| MounjaroTirzepatide | 34 | $35,902 |
| LinzessLinaclotide | 31 | $30,031 |
| Spiriva HandihalerTiotropium Bromide | 54 | $28,781 |
| OzempicSemaglutide | 24 | $28,525 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 29 | $26,143 |
| TradjentaLinagliptin | 30 | $23,082 |
| EntrestoSacubitril/Valsartan | 28 | $21,634 |
| JardianceEmpagliflozin | 14 | $19,561 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $18,004 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Verquvo | $86 | $143,731154 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $263 | $94,877127 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort, Breztri Aerosphere | $153 | $94,455132 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $128 | $74,80369 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $15 | $55,09715 claims |
| Boehringer IngelheimTradjenta, Jardiance | $54 | $42,64444 claims |
| PfizerEliquis, Prempro | $95 | $42,29670 claims |
| Novo NordiskOzempic, Levemir | $185 | $32,33560 claims |
| AbbVieLinzess | $217 | $30,03131 claims |
| NovartisEntresto | $259 | $21,63428 claims |
| Johnson & JohnsonXarelto | $20 | $16,43720 claims |
| Indivior Inc.Suboxone | $15 | $10,42081 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.
Other family in South Williamson
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.